NCT05641298: Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations |
|
|
| Withdrawn | 2 | 80 | US | Sodium Fusidate, ACG-701, ARV-1801, Placebo | Aceragen | Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | 09/23 | 09/23 | | |